Hemodynamic and histologic characterization of a swine (Sus scrofa domestica) model of chronic pulmonary arterial hypertension

Comparative Medicine

Volumn 61, Issue 3, 2011, Pages 258-262

  Rothman, Abraham ^a   Wiencek, Robert G ^b   Davidson, Stephanie ^c   Evans, William N ^a   Restrepo, Humberto ^a   Sarukhanov, Valeri ^a   Rivera Begeman, Amanda ^d   Mann, David ^e  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^b Cardiovascular Surgical Associates   (United States)

^c Anesthesiologist Consultants   (United States)

^d Laboratory Med Consultants Ltd   (United States)

^e Vascular BioSciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTOMOSIS; ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTOPULMONARY SHUNT; ARTICLE; BLOOD VESSEL BIOPSY; CHRONIC DISEASE; FEMALE; HEART HEMODYNAMICS; HISTOLOGY; NONHUMAN; PULMONARY HYPERTENSION; SURVIVAL RATE; SURVIVAL TIME; SWINE; ANIMAL; DISEASE MODEL; HEMODYNAMICS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY ARTERY; RADIOGRAPHY; THORACIC AORTA;

ANASTOMOSIS, SURGICAL; ANIMALS; AORTA, THORACIC; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; FEMALE; HEMODYNAMICS; HYPERTENSION, PULMONARY; PULMONARY ARTERY; SUS SCROFA;

EID: 84855988467     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Beppu H, Ichinose F, Kawai N, Jones RC, Yu PB, Zapol WM, Miyazono K, Li E, Bloch KD. 2004. BMPRII heterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxia. Am J Physiol Lung Cell Mol Physiol 287:L1241-L1247. (Pubitemid 39507203)
2. Berkenbosch JW, Baribeau J, Perreault T. 2000. Decreased synthesis and vasodilation to nitric oxide in piglets with hypoxia-induced pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 278:L276-L283. (Pubitemid 30131212)
3. Bousamra M 2nd, Rossi R, Jacobs E, Parviz M, Busch C, Nelin LD, Haworth S, Dawson CA. 2000. Systemic lobar shunting induces advanced pulmonary vasculopathy. J Thorac Cardiovasc Surg 120:88-98. (Pubitemid 30471216)
4. Chen EP, Bittner HB, Davis RD, Van Trigt P. 1997. Right ventricular failure - insights provided by a new model of chronic pulmonary hypertension. Transplantation 63:209-216. (Pubitemid 27121200)
5. Chen SJ, Chen IF, Meng QC, Durand J, Dicarlo VS, Oparil S. 1995. Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats. J Appl Physiol 79:2122-2131. (Pubitemid 26010587)
6. Clozel M, Hess P, Rey M, Iglarz M, Binkert C, Qiu C. 2006. Bosentan, sildenafil, and their combination in the monocrotaline model of pulmonary hypertension in rats. Exp Biol Med (Maywood) 231:967-973. (Pubitemid 43845561)
7. Corno AF, Tozzi P, Genton CY, von Segesser LK. 2003. Surgically induced unilateral pulmonary hypertension: time-related analysis of a new experimental model. Eur J Cardiothorac Surg 23:513-517. (Pubitemid 36411876)
8. Das M, Dempsey EC, Reeves JT, Stenmark KR. 2002. Selective expansion of fibroblast subpopulations from pulmonary artery adventitia in response to hypoxia. Am J Physiol Lung Cell Mol Physiol 282:L976-L986. (Pubitemid 34654614)
9. De Canniere D, Stefanidis C, Brimioulle S, Naeije R. 1994. Effects of a chronic aortopulmonary shunt on pulmonary hemodynamics in pigs. J Appl Physiol 77:1591-1596. (Pubitemid 24322408)
10. Drexler ES, Bischoff JE, Slifka AJ, McCowan CN, Quinn TP, Shandas R, Ivy DD, Stenmark KR. 2008. Stiffening of the extrapulmonary arteries from rats in chronic hypoxic pulmonary hypertension. J Res Natl Inst Stand Technol 113:239-249.
11. Ferguson DJ, Berkas EM, Varco RL. 1953. Circulatory factors contributin to alterations in pulmonary vascular histology. Surg Forum 4:267-270.
12. Frasch HF, Marshall C, Marshall BE. 1999. Endothelin 1 is elevated in monocrotaline pulmonary hypertension. Am J Physiol 276:L304-L310. (Pubitemid 29102272)
13. Galie N, Badesch D, Oudiz R, Simonneau G, McGoon MD, Keogh AM, Frost AE, Zwicke D, Naeije R, Shapiro S, Olschewski H, Rubin LJ. 2005. Ambrisentan therapy for pulmonary arterial hypertension. JACC 46:529-535. (Pubitemid 41040298)
14. Galie N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, Fleming T, Parpia T, Burgess G, Branzi A, Grimminger F, Kurzyna M, Simonneau G. 2005. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 353:2148-2157. (Pubitemid 41653106)
15. Guignabert C, Raffestin B, Benferhat R, Raoul W, Zadigue P, Rideau D, Hamon M, Adnot S, Eddahibi S. 2005. Serotonin transporter inhibition prevents and reverses monocrotaline pulmonary hypertension in rats. Circulation 111:2812-2819. (Pubitemid 40791554)
16. Gust R, Schuster DP. 2001. Vascular remodeling in experimentally induced subacute canine pulmonary hypertension. Exp Lung Res 27:1-12. (Pubitemid 32056097)
17. Hallioglu O, Dilber E, Celiker A. 2003. Comparison of acute hemodynamic effects of aerosolized and intravenous iloprost in secondary pulmonary hypertension in children with congenital heart disease. Am J Cardiol 92:1007-1009. (Pubitemid 37214824)
18. Institute for Laboratory Animal Research. 1996. Guide for the care and use of laboratory animals. Washington (DC): National Academies Press.
19. Ivy DD, McMurtry IF, Colvin K, Imamura M, Oka M, Lee DS, Gebb S, Jones PL. 2005. Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats: a new model of severe pulmonary arterial hypertension. Circulation 111:2988-2996. (Pubitemid 40814193)
20. Jungebluth P, Ostertag H, Macchiarini P. 2008. An experimental animal model of postobstructive pulmonary hypertension. J Surg Res 147:75-78.
21. Kim H, Yung GL, Marsh JJ, Konopka RG, Pedersen PG, Morris TA, Channick RN. 2000. Endothelin mediates pulmonary vascular remodeling in a canine model of chronic pulmonary hypertension. Eur Respir J 15:640-648. (Pubitemid 30196289)
22. Kolettis T, Vlahos AP, Louka M, Hatzistergos KE, Baltogiannis GG, Agelaki MM, Mitsi A, Malamou-Mitsi V. 2007. Characterization of a rat model of pulmonary arterial hypertension. Hellenic J Cardiol 48:206-210. (Pubitemid 47621071)
23. Laudi S, Steudel W, Jonscher K, Schoning W,Schniedewind B, Kaisers U, Christians U, Trump S. 2007. Comparison of lung proteome profiles in 2 rodent models of pulmonary arterial hypertension. Proteomics 7:2469-2478. (Pubitemid 47134539)
24. Maiya S, Hislop AA, Flynn Y, Haworth SG. 2006. Response to bosentan in children with pulmonary hypertension. Heart 92:664-670.
25. Marecki JC, Cool CD, Parr JE, Beckey VE, Luciw PA, Tarantal AF, Carville A, Shannon RP, Cotal-Gomez A, Tuder RM, Voelkel NF, Flores SC. 2006. HIV1 Nef is associated with complex pulmonary vascular lesions in SHIV-nef-infected macaques. Am J Respir Crit Care Med 174:437-445. (Pubitemid 44223125)
26. Mathew R, Zeballos GA, Tun H, Gewitz MH. 1995. Role of nitric oxide and endothelin 1 in monocrotaline-induced pulmonary hypertension. Cardiovasc Res 30:739-746.
27. Medhora M, Bousamra M 2nd, Zhu D, Somberg L, Jacobs ER. 2002. Upregulation of collagens detected by gene array in a model of flow-induced pulmonary vascular remodeling. Am J Physiol Heart Circ Physiol 282: H414-H422. (Pubitemid 34654963)
28. Muller WH, Dammann JF, Head WH. 1953. Changes in the pulmonary vessels produced by experimental pulmonary hypertension. Surgery 34:363-375.
29. Nishimura T, Faul JL, Berry GJ, Kao PN, Pearl RG. 2003. Effect of aortocaval fistula on monocrotaline-induced pulmonary hypertension. Crit Care Med 31:1213-1218. (Pubitemid 36444435)
30. Okada M, Yamashita C, Okada M, Okada K. 1995. Establishment of canine pulmonary hypertension with dehydromonocrotaline: importance of a larger animal model for lung transplantation. Transplantation 60:9-13.
31. Olschewski H, Simonneau G, Galie N, Higenbottam T, Naeije R, Rubin LJ, Nikkho S, Speich R, Hoeper MM, Behr J, Winkler J, Sitbon O, Popov W, Ghofrani HA, Manes A, Kiely DG, Ewert R, Meyer A, Corris PA, Delcroix M, Gomez-Sanchez M, Siedentop H, Seeger W. 2002. Aerosolized iloprost randomized study group. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 347:322-329. (Pubitemid 34815354)
32. Parviz M. Bousamra M 2nd, Chammas JH, Birks EK, Presberg KW, Jacobs ER, Nelin LD. 1999. Effects of chronic pulmonary overcirculation on pulmonary vasomotor tone. Ann Thorac Surg 67: 522-527. (Pubitemid 29181747)
33. Perkett EA, Davidson JM, Meyrick B. 1991. Sequence of structural change and elastin peptide release during vascular remodeling in sheep with chronic pulmonary hypertension induced by air embolization. Am J Pathol 139:1319-1332.
34. Rendas A, Reid L. 1979. Aorta-pulmonary shunts in growing pigs. Functional and structural assessment of the changes in the pulmonary circulation. J Thorac Cardiovasc Surg 77:109-118. (Pubitemid 9103560)
35. Rondelet B, Kerbaul F, Motte S, van Beneden R, Remmelink M, Brimioulle S, McEntee K, Wauthy P, Salmon I, Ketelsegers JM, Naeije R. 2003. Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension. Circulation 107:1329-1335. (Pubitemid 36314419)
36. Rosenkrantz JG, Carlisle JH, Lynch FP, Vogel JH. 1973. Ligation of a single pulmonary artery in the pig: a model of chronic pulmonary hypertension. J Surg Res 15:67-73.
37. Rosenzweig EB, Barst RJ. 2009. Pulmonary arterial hypertension in children: a medical update. Indian J Pediatr 76:77-81.
38. Rosenzweig EB, Ivy DD, Widlitz A, Doran A, Claussen LR, Yung D, Abman SH, Morganti A, Nguyen N, Barst RJ. 2005. Effects of long-term bosentan in children with pulmonary arterial hypertension. JACC 46:697-704. (Pubitemid 41132700)
39. Rosenzweig EB, Widlitz AC, Barst RJ. 2004. Pulmonary arterial hypertension in children. Pediatr Pulmonol 38:2-22. (Pubitemid 38823753)
40. Rothman A, Mann DM, Behling CA, Konopa RG, Chiles PG, Pedersen CA, Moser KM. 1998. Percutaneous pulmonary endoarterial biopsy in an experimental model of pulmonary hypertension. Chest 114:241-250. (Pubitemid 28337390)
41. Rothman A, Mann D, Behling CA, McGraw M, Seslar S, Shiu P, Zhang L, Kriett J. 2003. Increased expression of endoarterial vascular cell adhesion molecule 1 mRNA in an experimental model of lung transplant rejection: diagnosis by pulmonary arterial biopsy. Transplantation 75:960-965. (Pubitemid 36438522)
42. Rothman A, Mann DM, House MT, Konopka RG, Chiles PG, Pedersen CA, Wolf P, Moser KM. 1996. Transvenous procurement of pulmonary artery smooth muscle and endothelial cells using a novel endoarterial biopsy catheter in a canine model. J Am Coll Cardiol 27:218-224. (Pubitemid 26018935)
43. Sato H, Hall CM, Griffith GW, Johnson KF, McGillicuddy JW, Bartlett RH, Cook KE. 2008. Large animal model of chronic pulmonary hypertension. ASAIO Journal 54:396-400.
44. Schermuly RT, Kreisselmeier KP, Ghofrani HA, Yilmaz H, Butrous G, Ermert L, Ermert M, Weissmann N, Rose F, Guenther A, Walmrath D, Seeger W, Grimminger F. 2004. Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats. Am J Resp Crit Care Med 169:39-45. (Pubitemid 38233887)
45. Shelub I, van Grondelle A, McCulloggh R, Hofmeister S, Reeves JT. 1984. A model of embolic chronic pulmonary hypertension in the dog. J Appl Physiol 56:810-815. (Pubitemid 14149495)
46. Simonneau G, Barst RJ, Galie N, Naeije R, Rich S, Bourge RC, Keogh A, Oudiz R, Frost A, Blackburn SD, Crow JW, Rubin LJ; Treprostinil Study Group. 2002. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 165:800-804. (Pubitemid 34229650)
47. Song Y, Jones JE, Beppu H, Keaney JF Jr, Loscalzo J, Zhang YY. 2005. Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice. Circulation 112:553-562. (Pubitemid 41060796)
48. Stenmark KR, Fagan KA, Frid MG. 2006. Hypoxia-induced pulmonary vascular remodeling: celullar and molecular mechanisms. Circ Res 99:675-691. (Pubitemid 44498302)
49. Stenmark KR, Fasules J, Hyde DM, Voelkel NF, Henson J, Tucker A, Wilson H, Reeves JT. 1987. Severe pulmonary hypertension and arterial adventitia changes in newborn calves at 4300 m. J Appl Physiol 62:821-830. (Pubitemid 17066650)
50. Sugiura T, Suzuki S, Hussein MH, Kato T, Togari H. 2003. Usefulness of a new Doppler index for assessing both ventricular functions and pulmonary circulation in newborn piglets with hypoxic pulmonary hypertension. Pediatr Res 53:927-932. (Pubitemid 36666990)
51. Van Loon RL, Hoendermis ES, Duffels MG, Vonk-Noordegraaf A, Mulder BJ, Hillege HL, Berger RM. 2007. Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist? Am Heart J 154:776-782. (Pubitemid 47429578)
52. West J, Fagan K, Steudel W, Fouty B, Lane K, Harral J, Hoedt-Miller M, Tada Y, Ozimek J, Tuder R, Rodman DM. 2004. Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle. Circ Res 94:1109-1114. (Pubitemid 38579706)
53. White RJ, Meoli DF, Swarthout RF, Kallop DY, Galaria II, Harvey JL, Miller CM, Blaxall BC, Hall CM, Pierce RA, Cool CD, Taubman MB. 2007. Plexiforme-like lesions and increased tissue factor expression in a rat model of severe pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 293:L583-L590. (Pubitemid 47358820)